HomePosts Tagged "Philadelphia"

Burro is the leading plug-and-play autonomous robot available that increases productivity in conventional production environments

Philadelphia-based Burro, an autonomous mobility company providing solutions for the agriculture industry, announced today that it has launched a new product, Burro Grande, the company’s most powerful labour-saving robot. To date In terms of capabilities, Burro Grande expands beyond people scale (500 lb. payload, light-duty towing) to a true pallet-scale vehicle (1,500 lb. payloads, 5,000 lb. towing), and features Burro Operation System Software V 5.0 to enable indoor/outdoor LiDAR-based localisation for autonomous movement across indoor and outdoor operations.

All electric, the environmentally friendly Burro Grande will carry or tow heavy loads over multiple terrains for up to 15 miles between charges. When paired with the company’s Atlas Mission Autonomy, Burro’s online route creation platform, users can construct, manage and share routes across their fleet. Whether towing, carrying or following, Burro Grande allows your existing equipment operators to step away from the seat of a tractor or UTV, saving valuable labour.

Burro is the leading plug-and-play autonomous robot available that increases productivity in conventional production environments. It also features patent-pending Pop Up Autonomy™, which means the technology works immediately out of the box and empowers users on a job site to be up and running with very little training and can be used across multiple environments. Burro does not require centralised control or installation of burdensome infrastructure. Instead, its robots use computer vision (cameras) and AI to learn and to navigate autonomously from points A to B while carrying loads, as well as mowers and partner technology applications, such as artificial pollinators. Burro is proven to help agricultural clients realise improvements in efficiency by up to 40 per cent.

Burro is the leading plug-and-play autonomous robot

Announces strategic review of non-core assets including potential sale of FMC’s non-crop product line, Global Specialty Solutions

FMC Corporation hosted its Investor Day at FMC corporate headquarters in Philadelphia where the company introduced its new strategic growth plan, reviewed three-year financial goals and longer-term financial aspirations through 2033, and provided its preliminary outlook for 2024.  The company also outlined cost savings targets and key elements that will drive sustained profitable growth.

FMC’s strategic plan is anchored in three core ambitions: to strengthen the company’s relationship with growers, ensuring they receive sound, accurate and timely guidance about the right products and technologies that best address their needs; deliver superior growth and returns; and to maintain the company’s leadership in safety, sustainability and innovation.  Actions and specific plans that drive each ambition are summarised in eight strategic imperatives.

Mark Douglas, president and chief executive officer said,  “These range from strengthening our relationship with growers to ensure they have the best guidance on using the right technologies that address their needs, growing our leading Plant Health business, accelerating the discovery and commercialisation of our R&D pipeline, and increasing operating leverage that leads to a leaner organization.  Executing these initiatives will provide more valuable tools to growers to protect their crops while FMC achieves growth on the top and bottom line.”

Development and commercial launch of new products was a significant Investor Day theme, with Diane Allemang, executive vice president and chief marketing officer, presenting new patented formulations and mixtures of existing molecules, including FMC’s industry-leading diamides, as key drivers of revenue growth.  Dr Seva Rostovstev, vice president and chief technology officer, provided details on the R&D pipeline including four new active synthetic ingredients that are expected to provide approximately $2 billion of revenue by 2033.  New products and innovation were also key themes presented by the vice president and global Plant Health business director Dr Bénédicte Flambard, who outlined the company’s plan to grow FMC’s biologicals platform to approximately $2 billion in revenue by 2033.  Ronaldo Pereira, executive vice president and president of Americas, discussed how strengthening FMC’s relationship as a trusted advisor to growers will help support the new product introductions in the years to come.  Vice President of Procurement, Logistics and Global Facilities, Thaisa Hugenneyer reviewed how a resilient, agile, cost-efficient supply chain will support existing as well as new products throughout the strategic plan timeframe.

Announces strategic review of non-core assets including